Characteristics of medicine use for children with asthma in China: a nationwide population-based study
Abstract Objective To analyze the asthma medication use in Chinese children of different age groups, regions, and levels of cities in China, based on the 2015 Healthcare Insurance Data in China. Methods The China Healthcare Insurance Research Association (CHIRA) database was searched for children fr...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2022-12-01
|
| Series: | BMC Pediatrics |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12887-022-03720-5 |
| _version_ | 1797973467949170688 |
|---|---|
| author | Ping Wu Baoping Xu Adong Shen Huasong Zeng Kunling Shen |
| author_facet | Ping Wu Baoping Xu Adong Shen Huasong Zeng Kunling Shen |
| author_sort | Ping Wu |
| collection | DOAJ |
| description | Abstract Objective To analyze the asthma medication use in Chinese children of different age groups, regions, and levels of cities in China, based on the 2015 Healthcare Insurance Data in China. Methods The China Healthcare Insurance Research Association (CHIRA) database was searched for children from 0 to 14 years old diagnosed as asthma based on the “J45” and “J46” coded in ICD-10. A cross-sectional study design was employed. Results A total of 308,550 children were identified, all of whom were treated under the coverage of healthcare insurance. Among them, 2,468 children were eligible for inclusion in the present study. Compared with the current status of asthma care in European and American countries, under the guidelines for the diagnosis and treatment of asthma in China, the use percentages of ICS and short-acting β2 receptor agonist in children with asthma in China were lower, but the use percentages of oral corticosteroids, long-acting β2 receptor agonist, and theophylline (especially intravenous theophylline) were higher, especially in the Central and West China. Conclusion The asthma medication use was attributed to many factors, thus efforts are still needed to further popularize the GINA programs and China's guidelines for asthma diagnosis and treatment, especially in the Central and West China. |
| first_indexed | 2024-04-11T04:04:52Z |
| format | Article |
| id | doaj.art-26613c13d4c34381a97b890e2846f5a3 |
| institution | Directory Open Access Journal |
| issn | 1471-2431 |
| language | English |
| last_indexed | 2024-04-11T04:04:52Z |
| publishDate | 2022-12-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Pediatrics |
| spelling | doaj.art-26613c13d4c34381a97b890e2846f5a32023-01-01T12:27:41ZengBMCBMC Pediatrics1471-24312022-12-0122111210.1186/s12887-022-03720-5Characteristics of medicine use for children with asthma in China: a nationwide population-based studyPing Wu0Baoping Xu1Adong Shen2Huasong Zeng3Kunling Shen4Department of Allergy, Immunology and Rheumatology, Guangzhou Women and Children’s Medical Center, Guangzhou Medical UniversityChina National Clinical Research Center of Respiratory Diseases, Respiratory Department of Beijing Children’s Hospital, Capital Medical University, National Center for Children’s HealthChina National Clinical Research Center of Respiratory Diseases, Respiratory Department of Beijing Children’s Hospital, Capital Medical University, National Center for Children’s HealthDepartment of Allergy, Immunology and Rheumatology, Guangzhou Women and Children’s Medical Center, Guangzhou Medical UniversityChina National Clinical Research Center of Respiratory Diseases, Respiratory Department of Beijing Children’s Hospital, Capital Medical University, National Center for Children’s HealthAbstract Objective To analyze the asthma medication use in Chinese children of different age groups, regions, and levels of cities in China, based on the 2015 Healthcare Insurance Data in China. Methods The China Healthcare Insurance Research Association (CHIRA) database was searched for children from 0 to 14 years old diagnosed as asthma based on the “J45” and “J46” coded in ICD-10. A cross-sectional study design was employed. Results A total of 308,550 children were identified, all of whom were treated under the coverage of healthcare insurance. Among them, 2,468 children were eligible for inclusion in the present study. Compared with the current status of asthma care in European and American countries, under the guidelines for the diagnosis and treatment of asthma in China, the use percentages of ICS and short-acting β2 receptor agonist in children with asthma in China were lower, but the use percentages of oral corticosteroids, long-acting β2 receptor agonist, and theophylline (especially intravenous theophylline) were higher, especially in the Central and West China. Conclusion The asthma medication use was attributed to many factors, thus efforts are still needed to further popularize the GINA programs and China's guidelines for asthma diagnosis and treatment, especially in the Central and West China.https://doi.org/10.1186/s12887-022-03720-5PediatricsAsthmaMedicationHealthcare insurance data |
| spellingShingle | Ping Wu Baoping Xu Adong Shen Huasong Zeng Kunling Shen Characteristics of medicine use for children with asthma in China: a nationwide population-based study BMC Pediatrics Pediatrics Asthma Medication Healthcare insurance data |
| title | Characteristics of medicine use for children with asthma in China: a nationwide population-based study |
| title_full | Characteristics of medicine use for children with asthma in China: a nationwide population-based study |
| title_fullStr | Characteristics of medicine use for children with asthma in China: a nationwide population-based study |
| title_full_unstemmed | Characteristics of medicine use for children with asthma in China: a nationwide population-based study |
| title_short | Characteristics of medicine use for children with asthma in China: a nationwide population-based study |
| title_sort | characteristics of medicine use for children with asthma in china a nationwide population based study |
| topic | Pediatrics Asthma Medication Healthcare insurance data |
| url | https://doi.org/10.1186/s12887-022-03720-5 |
| work_keys_str_mv | AT pingwu characteristicsofmedicineuseforchildrenwithasthmainchinaanationwidepopulationbasedstudy AT baopingxu characteristicsofmedicineuseforchildrenwithasthmainchinaanationwidepopulationbasedstudy AT adongshen characteristicsofmedicineuseforchildrenwithasthmainchinaanationwidepopulationbasedstudy AT huasongzeng characteristicsofmedicineuseforchildrenwithasthmainchinaanationwidepopulationbasedstudy AT kunlingshen characteristicsofmedicineuseforchildrenwithasthmainchinaanationwidepopulationbasedstudy |